Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Reply to A Grigg et al

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Grigg A, Kimber R, Szer J . Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation. Leukemia ; 17: 1916–1917.

    Article  CAS  Google Scholar 

  2. Tedeschi A, Cairoli R, Marenco P, Nosari A, Tresoldi E, Di Bona E et al. Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation. Leukemia 2002; 16: 2455–2456.

    Article  CAS  Google Scholar 

  3. Jurcic JC . Antibody therapy for residual disease in acute myelogenous leukemia. Clin Rev Oncol Hematol 2001; 38: 37–45.

    Article  CAS  Google Scholar 

  4. Estey EH, Giles FJ, Kantarjian H, O'Brien S, Cortes J, Freireich EJ et al. Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Blood 1999; 94: 2230–2235.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tedeschi, A., Montillo, M. & Morra, E. Reply to A Grigg et al. Leukemia 17, 1918 (2003). https://doi.org/10.1038/sj.leu.2403051

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403051

Search

Quick links